Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Fusion Looking To Enter Cranial Surgery Sealant Market With Proceed Gel

This article was originally published in The Gray Sheet

Executive Summary

Fusion Medical sees a $35 mil. market opportunity for the cranial indication of the firm's Proceed hemostatic sealant, based on a projected per-kit price of $140 and more than 240,000 cranial procedures performed worldwide annually.

You may also be interested in...



Fusion Moving FAST To Test FloSeal Feasibility In 30-Patient IDE Study

Patient enrollment has begun at two sites in a randomized trial of the FloSeal Femoral Arteriotomy Sealing Technology (FAST) device, which is being developed by Fusion Medical for sealing femoral artery punctures created for diagnostic or therapeutic catheterization procedures.

Focal Seals FDA Panel Approval Recommendation For Lung Surgery Sealant

Focal, Inc. should include a warning in labeling for FocalSeal-L synthetic lung surgery sealant that higher risks of infection or empyema may be associated with use of the product, FDA's General and Plastic Surgery Devices Advisory Panel recommended at a May 8 meeting in Gaithersburg, Maryland.

Fusion Shipping FloSeal Hemostatic Sealant Following Dec. 8 FDA Approval

Fusion Medical Technologies commenced shipments of its FloSeal hemostatic sealant on Dec. 9 at a price of $125 for a 4 ml kit, following FDA approval Dec. 8.

UsernamePublicRestriction

Register

LL1135544

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel